Krebs Biochem
Company Overview - January 14, 2025
Krebs Biochem is a notable player in the Pharmaceuticals - Indian - Bulk Drugs industry, listed on both the BSE (Code: 524518) and NSE (Code: KREBSBIO). As of the January 14, 2025, the company holds a market capitalization of INR 232.85 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 108.00, Krebs Biochem has demonstrated a 37.89% return over the last year. Recent performance indicates fluctuations, with a 37.22% change in the past week and a 40.23% change over the last month. The company's all-time high stands at INR 227.95, while its lowest-ever price was INR 9.08.
In terms of sales, Krebs Biochem reported a revenue of INR 50.70 crores, solidifying its position in the market. The average trading volume over the past month has been 93571 shares, with a more recent weekly average of 335264.
With the stock trading above its 50-day moving average of INR 88.15, the company's technical indicators like MACD (6.99) signal positive trends.
Company Data
| Name | Krebs Biochem |
|---|---|
| BSE Code | 524518 |
| NSE Code | KREBSBIO |
| Industry | Pharmaceuticals - Indian - Bulk Drugs |
| Current Price | 108.00 |
| Market Capitalization | 232.85 |
| Sales | 50.70 |
| Return over 3months | 34.38 |
| Return over 6months | 82.15 |
| Volume 1month average | 93571 |
| Volume 1week average | 335264 |
| Volume | 119513 |
| High price | 129.07 |
| Low price | 60.00 |
| High price all time | 227.95 |
| Low price all time | 9.08 |
| Return over 1day | -4.54 |
| Return over 1week | 37.22 |
| Return over 1month | 40.23 |
| Return over 1year | 37.89 |
| Return over 3years | -12.07 |
| Return over 5years | 3.63 |
| Volume 1year average | 54498 |
| DMA 50 | 88.15 |
| DMA 200 | 81.55 |
| DMA 50 previous day | 87.14 |
| DMA 200 previous day | 81.24 |
| MACD | 6.99 |
| MACD Signal | 3.32 |